The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial.
Kataoka Y, Kitahara S, Funabashi S, Makino H, Matsubara M, Matsuo M, Omura-Ohata Y, Koezuka R, Tochiya M, Tamanaha T, Tomita T, Honda-Kohmo K, Noguchi M, Maruki M, Kanai E, Murai K, Iwai T, Sawada K, Matama H, Honda S, Fujino M, Yoneda S, Takagi K, Otsuka F, Asaumi Y, Hosoda K, Nicholls SJ, Yasuda S, Noguchi T.
Kataoka Y, et al. Among authors: kanai e.
J Diabetes Complications. 2023 Oct;37(10):108592. doi: 10.1016/j.jdiacomp.2023.108592. Epub 2023 Aug 23.
J Diabetes Complications. 2023.
PMID: 37741088
Free article.
Clinical Trial.